Developing an Ecological and Tailored Nutritional Intervention to Improve Quality of Life in Esophageal Cancer Survivors
2 other identifiers
interventional
30
1 country
1
Brief Summary
This study aims to apply and assess the clinical feasibility of a health behavior theory-based ecological nutrition intervention program, providing nutrition care tailored to the unmet needs of esophageal cancer survivors after surgery. Esophageal cancer survivors will receive a 4-week nutrition intervention program tailored to their individual nutritional needs. The program includes providing nutritional guidelines, customized care food, encouraging walking through a wearable device, and weekly telephone counseling. The evaluation of the program will assess food intake, adherence to dietary guidelines, activity level, nutritional indicators (such as PNI and NRI), weight change, fatigue, symptoms, quality of life, and satisfaction with meals and services. Additionally, interviews will be conducted after the intervention to evaluate the patient's experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 3, 2025
CompletedFirst Submitted
Initial submission to the registry
May 12, 2025
CompletedFirst Posted
Study publicly available on registry
June 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJune 17, 2025
June 1, 2025
9 months
May 12, 2025
June 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survey Questionnaire on Health Behavior Change through an Intervention Program
Adherence to nutritional guidelines including food intake
Baseline, end of intervention (post-enrollment 4 weeks)
Secondary Outcomes (11)
Change in body weight (kg)
Baseline, end of intervention (post-enrollment 4 weeks)
Change in body composition (fat mass and fat-free mass)
Baseline, end of intervention (post-enrollment 4 weeks)
Change in Body Mass Index (BMI) (kg/m²)
Baseline, end of intervention (post-enrollment 4 weeks)
Change in Patient-Generated Subjective Global Assessment Short Form (PG-SGA-SF) score
Baseline, end of intervention (post-enrollment 4 weeks)
Change in Gastrointestinal Symptom Rating Scale (GSRS) score
Baseline, end of intervention (post-enrollment 4 weeks)
- +6 more secondary outcomes
Other Outcomes (11)
Change in grip strength (kg)
Baseline, end of intervention (post-enrollment 4 weeks)
Change in serum albumin (g/dL)
Baseline, end of intervention (post-enrollment 4 weeks)
Change in prealbumin (mg/dL)
Baseline, end of intervention (post-enrollment 4 weeks)
- +8 more other outcomes
Study Arms (1)
Nutrition Intervention group
EXPERIMENTALThis is a single-arm study, with all participants in the intervention arm. Patients in the intervention arm will receive a 4-week nutrition management program.
Interventions
Patients in the intervention arm will receive a 4-week nutrition management program(1 week for patients more than 4 months post-surgery), which includes providing nutritional guidelines, home delivery of personalized care foods, encouragement of physical activity using a wearable device, and weekly phone calls to check on nutritional goals and symptoms. Management services are also available through the mobile application.
Eligibility Criteria
You may qualify if:
- Patients with clinical stage 1-3 primary esophageal cancer at diagnosis who have planned or received treatment, including esophageal resection and reconstruction, with curative intent, and their families\*.
- You are at least 18 years of age
- Have a native-level understanding of Korean
- Who consented to this study
You may not qualify if:
- Concurrent multiple cancers at the time of diagnosis or a history of diagnosed and treated other organ cancers within the past year at the time of diagnosis
- Have had esophageal resection and reconstruction surgery for other reasons before being diagnosed with esophageal cancer
- Persons with limited cognitive and communication abilities
- The patient has had problems progressing to oral feeding after surgery, requiring a concurrent ileostomy, or the investigator determines that an interventional study is not appropriate.
- Individuals with reduced renal function for whom protein intake is not recommended (estimated GFR \<60 mL/min/1.73 m2)
- People who are unable to walk due to joint problems, paralysis, etc.
- Those who do not use smartphones
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center
Seoul, Seoul, 06351, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juhee Cho, PhD
Samsung Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Cancer Education Center
Study Record Dates
First Submitted
May 12, 2025
First Posted
June 17, 2025
Study Start
April 3, 2025
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
June 17, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share